Biogemic amines in seasonal affective disorder: Effects of light therapy

[1]  J. Mooney,et al.  Changes in norepinephrine output following light therapy for fall/winter seasonal depression , 1992, Biological Psychiatry.

[2]  M. Stein,et al.  Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders. Comparison of patients with panic disorder and social phobia and normal control subjects. , 1992, Archives of general psychiatry.

[3]  S. Kasper,et al.  Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications. , 1991, The Journal of clinical endocrinology and metabolism.

[4]  J. Hsiao,et al.  The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects. , 1991, Archives of general psychiatry.

[5]  W. Potter,et al.  Hypothalamic-pituitary-adrenal axis and monoamine transmitter activity in depression: A pilot study of central and peripheral effects of electroconvulsive therapy , 1991, Biological Psychiatry.

[6]  S. Dager,et al.  Morning or evening bright light treatment of winter depression? The significance of hypersomnia , 1991, Biological Psychiatry.

[7]  D. M. White,et al.  Morning vs evening light treatment for winter depression. Evidence that the therapeutic effects of light are mediated by circadian phase shifts. , 1990, Archives of general psychiatry.

[8]  R. McGrath,et al.  The effect of L-tryptophan on seasonal affective disorder. , 1990, The Journal of clinical psychiatry.

[9]  F. Goodwin Manic-Depressive Illness , 1990 .

[10]  M. Blehar,et al.  Seasonal mood disorders: consensus and controversy. , 1990, Psychopharmacology bulletin.

[11]  R. Gianrossi,et al.  Plasma dopamine response to sympathetic activation in man: a biphasic pattern. , 1990, Life sciences.

[12]  R. Gleason,et al.  Treatment of seasonal depression with d-fenfluramine. , 1989, The Journal of clinical psychiatry.

[13]  M Terman,et al.  Light therapy for seasonal affective disorder. A review of efficacy. , 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[14]  C. C. Duncan,et al.  Neurobiology of Seasonal Affective Disorder and Phototherapy , 1988, Journal of biological rhythms.

[15]  T. Wehr,et al.  Phototherapy for Seasonal Affective Disorder , 1988, Journal of biological rhythms.

[16]  J. Nurnberger,et al.  Analysis of seasonal fluctuations of CSF monoamine metabolites and neuropeptides in normal controls: Findings with 5HIAA and HVA , 1988, Psychiatry Research.

[17]  T. Wehr,et al.  The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions. , 1988, Archives of general psychiatry.

[18]  J. Hsiao,et al.  ECT alters human monoamines in a different manner from that of antidepressant drugs. , 1988, Psychopharmacology bulletin.

[19]  J. Hsiao,et al.  Monoamine neurotransmitter interactions and the prediction of antidepressant response. , 1987, Archives of general psychiatry.

[20]  T. Wehr,et al.  Neuroendocrine response to 5-hydroxytryptophan in seasonal affective disorder. , 1987, Archives of general psychiatry.

[21]  J. Hsiao,et al.  The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5‐hydroxyindoleacetic acid ratio , 1987, Clinical pharmacology and therapeutics.

[22]  T. Wehr,et al.  Morning versus midday phototherapy of seasonal affective disorder. , 1987, The American journal of psychiatry.

[23]  M Linnoila,et al.  Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF. , 1986, Journal of psychiatric research.

[24]  M. Scheinin,et al.  Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites. , 1985, Archives of general psychiatry.

[25]  D. Pickar,et al.  Plasma norepinephrine level in affective disorders. Relationship to melancholia. , 1985, Archives of general psychiatry.

[26]  W. Potter,et al.  Exaggerated orthostatic responsivity of plasma norepinephrine in depression. , 1985, Archives of general psychiatry.

[27]  M. Scheinin,et al.  Liquid chromatographic assay for CSF catecholamines using electrochemical detection. , 1984, Acta pharmacologica et toxicologica.

[28]  F. Goodwin,et al.  Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. , 1984, Archives of general psychiatry.

[29]  S. Koslow,et al.  CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. , 1983, Archives of general psychiatry.

[30]  M. Scheinin,et al.  Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection. , 1983, Analytical biochemistry.

[31]  H. Calil,et al.  Effects of desmethylimipramine on plasma norepinephrine, pulse, and blood pressure , 1983, Clinical pharmacology and therapeutics.

[32]  M. F. Sugrue,et al.  Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning. , 1983, Pharmacology & therapeutics.

[33]  E. Robins,et al.  Research diagnostic criteria: rationale and reliability. , 1978, Archives of general psychiatry.

[34]  F. Goodwin,et al.  Effect of diet on urinary MHPG excretion in depressed patients and normal control subjects. , 1977, The American journal of psychiatry.

[35]  I. Kopin,et al.  Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. , 1976, Life sciences.